JUPITER NEUROSCIENCES, INC.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
DE
Business Address
1001 NORTH US HWY 1, JUPITER, FL, 33477
Mailing Address
1001 NORTH US HWY 1, JUPITER, FL, 33477
Phone
(561) 406-6154
Fiscal Year End
1231
EIN
474828381
Financial Overview
FY2025 FY
$22K
Revenue
$4.17M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | April 1, 2026 | View on SEC |
| 8-K Current report of material events | February 27, 2026 | View on SEC |
| 8-K Current report of material events | February 20, 2026 | View on SEC |
| 8-K Current report of material events | December 23, 2025 | View on SEC |
| 8-K Current report of material events | December 22, 2025 | View on SEC |
| S-1 IPO registration statement | November 26, 2025 | View on SEC |
| 8-K/A Current report amendment | November 20, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 14, 2025 | View on SEC |
| DEF 14A Definitive proxy statement | November 6, 2025 | View on SEC |
| 8-K Current report of material events | October 27, 2025 | View on SEC |
Annual Reports
10-K
April 1, 2026
- Development of JOTROL™, a specialized resveratrol formulation for Parkinson’s and Friedreich’s Ataxia.
- Launch of Nugevia, a consumer wellness brand designed to generate operational cash flow.
Material Events
8-K
Financial Distress
February 27, 2026
High Impact
- JUPITER NEUROSCIENCES, INC. (JUNS) received two official Nasdaq warning letters.
- The company is failing to meet Nasdaq's minimum bid price ($1.00) and Market Value of Listed Securities ($35 million) requirements.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.